2931 Stock Overview
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Euglena Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥605.00 |
52 Week High | JP¥966.00 |
52 Week Low | JP¥588.00 |
Beta | 0 |
1 Month Change | 0.33% |
3 Month Change | -16.55% |
1 Year Change | -35.84% |
3 Year Change | -42.87% |
5 Year Change | -11.94% |
Change since IPO | 286.83% |
Recent News & Updates
Recent updates
Shareholder Returns
2931 | JP Personal Products | JP Market | |
---|---|---|---|
7D | -4.0% | -2.1% | 1.7% |
1Y | -35.8% | -15.3% | 37.6% |
Return vs Industry: 2931 underperformed the JP Personal Products industry which returned -15.1% over the past year.
Return vs Market: 2931 underperformed the JP Market which returned 38.6% over the past year.
Price Volatility
2931 volatility | |
---|---|
2931 Average Weekly Movement | 4.3% |
Personal Products Industry Average Movement | 3.7% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 8.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2931 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2931's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 846 | Tomohiro Wakahara | https://www.euglena.jp |
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. The company operates through two segments, Healthcare Business and Energy/Environment Business. It also manufactures and sells foods and cosmetics using euglena.
Euglena Co., Ltd. Fundamentals Summary
2931 fundamental statistics | |
---|---|
Market cap | JP¥81.46b |
Earnings (TTM) | -JP¥2.65b |
Revenue (TTM) | JP¥46.48b |
1.8x
P/S Ratio-30.7x
P/E RatioIs 2931 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2931 income statement (TTM) | |
---|---|
Revenue | JP¥46.48b |
Cost of Revenue | JP¥14.71b |
Gross Profit | JP¥31.78b |
Other Expenses | JP¥34.43b |
Earnings | -JP¥2.65b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -19.70 |
Gross Margin | 68.36% |
Net Profit Margin | -5.71% |
Debt/Equity Ratio | 124.0% |
How did 2931 perform over the long term?
See historical performance and comparison